Two distinctive antinociceptive systems in rats with pathological pain
Section snippets
Acknowledgements
This work was supported by the PHS grant DA08835. Δ9-tetrahydrocannabinol was kindly provided by Dr. Bill Martin at Medical College of Virginia.
References (18)
- et al.
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
Pain
(1988) - et al.
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Pain
(1988) - et al.
The analgesic effect of R(+)-Win 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
Neurosci. Lett.
(1997) - et al.
Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia
Lancet
(1992) - et al.
Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
Pain
(1995) - et al.
Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions
Pain
(1995) - et al.
The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
Neurosci. Lett.
(1995) - et al.
Potentiation of delta-9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors
Eur. J. Pharmacol.
(1996) - et al.
SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
Eur. J. Pharmacol.
(1997)
Cited by (99)
Central and peripheral anti-hyperalgesic effects of diosmin in a neuropathic pain model in rats
2018, Biomedicine and PharmacotherapyCannabidiol-Δ<sup>9</sup>-tetrahydrocannabinol interactions on acute pain and locomotor activity
2017, Drug and Alcohol DependenceSynergistic antinociceptive interaction between palmitoylethanolamide and tramadol in the mouse formalin test
2015, European Journal of PharmacologySkin β-endorphin mediates addiction to UV light
2014, CellCitation Excerpt :On the day following the final day of conditioning, place preferences were again tested (postconditioning, 10 min testing time per mouse). Morphine dose-response curves in the hot-plate test were measured as described elsewhere (Mao et al., 2000) in mice that had undergone 6 weeks of UV exposure or mock treatment. Morphine was injected at a starting dose of 0.02 mg/kg i.p. and was increased logarithmically in cumulative dose increments of 0.3 log units.
Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice
2011, Pharmacology Biochemistry and BehaviorCitation Excerpt :Low dose cannabinoid enhanced the antinociceptive effect of morphine; a similar synergy was also shown when low dose opioid was used (Reche et al., 1996; Smith et al., 1998). On the contrary, the same synergy was not observed in neuropathic rats, indicating the existence of two distinctive antinociceptive systems in pathological pain (Mao et al., 2000). However, a synergistic effect with the combination of drugs affecting cannabinoid and N/OFQ systems might also be expected, since increased N/OFQ levels and upregulation in the NOP receptor have been shown (Briscini et al., 2002; Mika et al., 2004), and NOP receptor antagonists have been effective in neuropathic pain states (Mabuchi et al., 2003; Suyama et al., 2003; Tamai et al., 2005; Khroyan et al., 2009).